{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:17Z","timestamp":1787020157023,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["#PI00-0745"],"award-info":[{"award-number":["#PI00-0745"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["#PI06-1614"],"award-info":[{"award-number":["#PI06-1614"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"european urological scholarship program for research","award":["S-01-2013"],"award-info":[{"award-number":["S-01-2013"]}]},{"name":"Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en C\u00e1ncer","award":["(#RD12\/0036\/0050"],"award-info":[{"award-number":["(#RD12\/0036\/0050"]}]},{"name":"Instituto de Saludo Carlos III","award":["#PI05-1436"],"award-info":[{"award-number":["#PI05-1436"]}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Intramural Research Program, Division of Cancer Epidemiology and Genetics","award":["NCI NO2-CP-11015"],"award-info":[{"award-number":["NCI NO2-CP-11015"]}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["EU-FP7-HEALTH-F2-2008-201663-UROMOL"],"award-info":[{"award-number":["EU-FP7-HEALTH-F2-2008-201663-UROMOL"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["EU-7FP-HEALTH-TransBioBC #601933"],"award-info":[{"award-number":["EU-7FP-HEALTH-TransBioBC #601933"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2361-7","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T12:51:30Z","timestamp":1464958290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models"],"prefix":"10.1186","volume":"16","author":[{"name":"On behalf of the SBC\/EPICURO Study Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"L\u00f3pez de Maturana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Picornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Masson-Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kogevinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Carrato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tard\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lloreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garc\u00eda-Closas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chanock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. X.","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Malats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,3]]},"reference":[{"key":"2361_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893\u2013917.","journal-title":"Int J Cancer"},{"key":"2361_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","volume":"27","author":"KD Sievert","year":"2009","unstructured":"Sievert KD, Amend B, Nagele U, Schilling D, Bedke J, Horstmann M, Hennenlotter J, Kruck S, Stenzl A. Economic aspects of bladder cancer: What are the benefits and costs? World J Urol. 2009;27:295\u2013300.","journal-title":"World J Urol"},{"key":"2361_CR3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, Van Der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DWW, Kurth K. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466\u201375.","journal-title":"Eur Urol"},{"key":"2361_CR4","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","volume":"182","author":"J Fernandez-Gomez","year":"2009","unstructured":"Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Pi\u00f1eiro L, Gonzalez M, Portillo J, Ojea A, Pertusa C, Rodriguez-Molina J, Camacho JE, Rabadan M, Astobieta A, Montesinos M, Isorna S, Munta\u00f1ola P, Gimeno A, Blas M, Martinez-Pi\u00f1eiro JA. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. J Urol. 2009;182:2195\u2013203.","journal-title":"J Urol"},{"key":"2361_CR5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.eururo.2011.06.001","volume":"60","author":"RJ Sylvester","year":"2011","unstructured":"Sylvester RJ. How well can you actually predict which non-muscle-invasive bladder cancer patients will progress? Eur Urol. 2011;60:431\u20133.","journal-title":"Eur Urol"},{"key":"2361_CR6","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1002\/cncr.27587","volume":"118","author":"F Thomas","year":"2012","unstructured":"Thomas F, Rosario DJ, Rubin N, Goepel JR, Abbod MF, Catto JWF. The long-term outcome of treated high-risk nonmuscle-invasive bladder cancer: time to change treatment paradigm? Cancer. 2012;118:5525\u201334.","journal-title":"Cancer"},{"key":"2361_CR7","doi-asserted-by":"crossref","first-page":"e89164","DOI":"10.1371\/journal.pone.0089164","volume":"9","author":"AJ Grotenhuis","year":"2014","unstructured":"Grotenhuis AJ, Dudek AM, Verhaegh GW, Witjes JA, Aben KK, van der Marel SL, Vermeulen SH, Kiemeney LA. Prognostic relevance of urinary bladder cancer susceptibility loci. PLoS One. 2014;9:e89164.","journal-title":"PLoS One"},{"key":"2361_CR8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1158\/1940-6207.CAPR-10-0035","volume":"3","author":"M Chen","year":"2010","unstructured":"Chen M, Hildebrandt MAT, Clague J, Kamat AM, Picornell A, Chang J, Zhang X, Izzo J, Yang H, Lin J, Gu J, Chanock S, Kogevinas M, Rothman N, Silverman DT, Garcia-Closas M, Barton Grossman H, Dinney CP, Malats N, Wu X. Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer. Cancer Prev Res. 2010;3:1235\u201345.","journal-title":"Cancer Prev Res"},{"key":"2361_CR9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ng.608","volume":"42","author":"J Yang","year":"2010","unstructured":"Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, et al. Common {SNPs} explain a large proportion of the heritability for human height. Nat Gen. 2010;42:565\u20139.","journal-title":"Nat Gen"},{"key":"2361_CR10","doi-asserted-by":"crossref","first-page":"e1002051","DOI":"10.1371\/journal.pgen.1002051","volume":"7","author":"R Makowsky","year":"2011","unstructured":"Makowsky R, Pajewski NM, Klimentidis YC, Vazquez AI, Duarte CW, Allison DB, de los Campos G. Beyond missing heritability: prediction of complex traits. PLoS Genet. 2011;7:e1002051.","journal-title":"PLoS Genet"},{"key":"2361_CR11","volume-title":"Genomewide pronostic study in bladder cancer","author":"AC Picornell","year":"2013","unstructured":"Picornell AC. Genomewide pronostic study in bladder cancer. 2013."},{"key":"2361_CR12","volume-title":"Package \u201crandomForest.\u201d","author":"A Liaw","year":"2015","unstructured":"Liaw A, Wiener M. Package \u201crandomForest.\u201d. 2015."},{"key":"2361_CR13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.0006-341X.2001.00829.x","volume":"57","author":"JH Albert","year":"2001","unstructured":"Albert JH, Chib S. Sequential ordinal modeling with applications to survival data. Biometrics. 2001;57:829\u201336.","journal-title":"Biometrics"},{"key":"2361_CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3168\/jds.S0022-0302(95)76630-9","volume":"78","author":"PM Visscher","year":"1995","unstructured":"Visscher PM, Goddard ME. Genetic parameters for milk yield, survival, workability, and type traits for Australian dairy cattle. J Dairy Sci. 1995;78:205\u201320.","journal-title":"J Dairy Sci"},{"issue":"0999-193X (Prin","key":"2361_CR15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1297-9686-39-4-391","volume":"39","author":"O Gonzalez-Recio","year":"2007","unstructured":"Gonzalez-Recio O, Alenda R. Genetic relationship of discrete-time survival with fertility and production in dairy cattle using bivariate models. Genet Evol. 2007;39(0999-193X (Print):391\u2013404.","journal-title":"Genet Evol"},{"key":"2361_CR16","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1534\/genetics.103.025734","volume":"167","author":"D Gianola","year":"2004","unstructured":"Gianola D, Sorensen D. Quantitative genetic models for describing simultaneous and recursive relationships between phenotypes. Genetics. 2004;167:1407\u201324.","journal-title":"Genetics"},{"key":"2361_CR17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1198\/016214508000000337","volume":"103","author":"T Park","year":"2008","unstructured":"Park T, Casella G. The Bayesian lasso. J Am Stat Assoc. 2008;103:681\u20136.","journal-title":"J Am Stat Assoc"},{"key":"2361_CR18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1534\/genetics.109.101501","volume":"182","author":"CG Los De","year":"2009","unstructured":"De Los CG, Naya H, Gianola D, Crossa J, Legarra A, Manfredi E, Weigel K, Cotes JM. Predicting quantitative traits with regression models for dense molecular markers and pedigree. Genetics. 2009;182:375\u201385.","journal-title":"Genetics"},{"key":"2361_CR19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/gepi.21809","volume":"38","author":"EL Maturana de","year":"2014","unstructured":"de Maturana EL, Chanok SJ, Picornell AC, Rothman N, Herranz J, Calle ML, Garc\u00eda-Closas M, Marenne G, Brand A, Tard\u00f3n A, Carrato A, Silverman DT, Kogevinas M, Gianola D, Real FX, Malats N. Whole genome prediction of bladder cancer risk with the Bayesian LASSO. Genet Epidemiol. 2014;38:467\u201376.","journal-title":"Genet Epidemiol"},{"key":"2361_CR20","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The elements of statistical learning: data mining, inference, and prediction","author":"T Hastie","year":"2009","unstructured":"Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference, and prediction. 2009."},{"key":"2361_CR21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/gepi.21614","volume":"36","author":"SH Lee","year":"2012","unstructured":"Lee SH, Goddard ME, Wray NR, Visscher PM. A better coefficient of determination for genetic profile analysis. Genet Epidemiol. 2012;36:214\u201324.","journal-title":"Genet Epidemiol"},{"key":"2361_CR22","doi-asserted-by":"crossref","first-page":"429213","DOI":"10.1155\/2012\/429213","volume":"2012","author":"E Martino Di","year":"2012","unstructured":"Di Martino E, Tomlinson DC, Knowles MA. A decade of FGF receptor research in bladder cancer: past, present, and future challenges. Adv Urol. 2012;2012:429213.","journal-title":"Adv Urol"},{"key":"2361_CR23","first-page":"651","volume":"32","author":"I Karaoglu","year":"2014","unstructured":"Karaoglu I, van der Heijden AG, Witjes JA. The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer. World J Urol. 2014;32:651\u20139.","journal-title":"World J Urol"},{"key":"2361_CR24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00345-010-0635-2","volume":"29","author":"V Hern\u00e1ndez","year":"2011","unstructured":"Hern\u00e1ndez V, De La Pe\u00f1a E, Martin MD, Bl\u00e1zquez C, Diaz FJ, Llorente C. External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer. World J Urol. 2011;29:409\u201314.","journal-title":"World J Urol"},{"key":"2361_CR25","doi-asserted-by":"crossref","first-page":"e96849","DOI":"10.1371\/journal.pone.0096849","volume":"9","author":"MM Vedder","year":"2014","unstructured":"Vedder MM, M\u00e1rquez M, de Bekker-Grob EW, Calle ML, Dyrskj\u00f8t L, Kogevinas M, Segersten U, Malmstr\u00f6m P-U, Algaba F, Beukers W, \u00d8rntoft TF, Zwarthoff E, Real FX, Malats N, Steyerberg EW. Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours. PLoS One. 2014;9:e96849.","journal-title":"PLoS One"},{"key":"2361_CR26","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2011.03.023","volume":"59","author":"A Stenzl","year":"2011","unstructured":"Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol. 2011;59:1009\u201318.","journal-title":"Eur Urol"},{"key":"2361_CR27","doi-asserted-by":"crossref","unstructured":"Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, B\u00f6hle A, Palou-Redorta J, Roupr\u00eat M. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol. 2011;59:997\u20131008.","DOI":"10.1016\/j.eururo.2011.03.017"},{"key":"2361_CR28","doi-asserted-by":"crossref","first-page":"e1005048","DOI":"10.1371\/journal.pgen.1005048","volume":"11","author":"CG Los de","year":"2015","unstructured":"de Los CG, Sorensen D, Gianola D. Genomic heritability: what is it? PLoS Genet. 2015;11:e1005048.","journal-title":"PLoS Genet"},{"key":"2361_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1055-9965.EPI-10-0329","volume":"20","author":"M Zitteren Van","year":"2011","unstructured":"Van Zitteren M, Van Der Net JB, Kundu S, Freedman AN, Van Duijn CM, Janssens ACJW. Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associations. Cancer Epidemiol Biomarkers Prev. 2011;20:9\u201322.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2361_CR30","doi-asserted-by":"crossref","unstructured":"Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, Thun MJ, Cox DG, Hankinson SE, Kraft P, Rosner B, Berg CD, Brinton L a, Lissowska J, Sherman ME, Chlebowski R, Kooperberg C, Jackson RD, Buckman DW, Hui P, Pfeiffer R, Jacobs KB, Thomas GD, Hoover RN, Gail MH, Chanock SJ, Hunter DJ. Performance of common genetic variants in breast-cancer risk models. N Engl J Med. 2010;362:986\u201393.","DOI":"10.1056\/NEJMoa0907727"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2361-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T10:30:01Z","timestamp":1526639401000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2361-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2361"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2361-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,3]]},"article-number":"351"}}